栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/03/25 | 1,978 | 1,981 | 1,949 | 1,958 | -36 | -1.8% | 95,500 |
| 2024/03/22 | 1,967 | 2,006 | 1,967 | 1,994 | +27 | +1.4% | 130,500 |
| 2024/03/21 | 1,973 | 1,980 | 1,924 | 1,967 | +6 | +0.3% | 254,000 |
| 2024/03/19 | 1,937 | 1,982 | 1,921 | 1,961 | +29 | +1.5% | 219,500 |
| 2024/03/18 | 1,919 | 1,939 | 1,912 | 1,932 | +32 | +1.7% | 129,500 |
| 2024/03/15 | 1,931 | 1,931 | 1,885 | 1,900 | -31 | -1.6% | 258,100 |
| 2024/03/14 | 1,982 | 1,982 | 1,914 | 1,931 | -51 | -2.6% | 200,200 |
| 2024/03/13 | 2,018 | 2,029 | 1,948 | 1,982 | -30 | -1.5% | 158,600 |
| 2024/03/12 | 1,986 | 2,021 | 1,963 | 2,012 | +2 | +0.1% | 280,200 |
| 2024/03/11 | 1,880 | 2,055 | 1,874 | 2,010 | +105 | +5.5% | 766,800 |
| 2024/03/08 | 1,900 | 1,921 | 1,891 | 1,905 | -4 | -0.2% | 179,400 |
| 2024/03/07 | 1,903 | 1,926 | 1,902 | 1,909 | +9 | +0.5% | 132,500 |
| 2024/03/06 | 1,900 | 1,921 | 1,889 | 1,900 | +8 | +0.4% | 134,700 |
| 2024/03/05 | 1,889 | 1,905 | 1,879 | 1,892 | -7 | -0.4% | 329,300 |
| 2024/03/04 | 1,905 | 1,944 | 1,890 | 1,899 | -1 | -0.1% | 223,400 |
| 2024/03/01 | 1,870 | 1,906 | 1,851 | 1,900 | +12 | +0.6% | 351,200 |
| 2024/02/29 | 1,880 | 1,898 | 1,871 | 1,888 | +8 | +0.4% | 142,200 |
| 2024/02/28 | 1,889 | 1,931 | 1,879 | 1,880 | +4 | +0.2% | 146,400 |
| 2024/02/27 | 1,856 | 1,890 | 1,852 | 1,876 | +20 | +1.1% | 153,200 |
| 2024/02/26 | 1,878 | 1,895 | 1,850 | 1,856 | -7 | -0.4% | 107,500 |
| 2024/02/22 | 1,868 | 1,869 | 1,838 | 1,863 | -14 | -0.7% | 130,800 |
| 2024/02/21 | 1,889 | 1,902 | 1,860 | 1,877 | +3 | +0.2% | 98,700 |
| 2024/02/20 | 1,896 | 1,898 | 1,873 | 1,874 | -22 | -1.2% | 142,400 |
| 2024/02/19 | 1,911 | 1,918 | 1,883 | 1,896 | -15 | -0.8% | 88,700 |
| 2024/02/16 | 1,935 | 1,935 | 1,906 | 1,911 | +3 | +0.2% | 133,300 |
| 2024/02/15 | 1,959 | 1,964 | 1,902 | 1,908 | -32 | -1.6% | 140,400 |
| 2024/02/14 | 1,950 | 1,964 | 1,931 | 1,940 | -10 | -0.5% | 125,400 |
| 2024/02/13 | 1,943 | 1,962 | 1,926 | 1,950 | +7 | +0.4% | 151,200 |
| 2024/02/09 | 1,939 | 1,962 | 1,938 | 1,943 | +4 | +0.2% | 143,100 |
| 2024/02/08 | 1,930 | 1,957 | 1,915 | 1,939 | ±0 | ±0% | 123,900 |
| 2024/02/07 | 1,950 | 1,960 | 1,922 | 1,939 | -6 | -0.3% | 175,900 |
| 2024/02/06 | 1,947 | 1,959 | 1,907 | 1,945 | -6 | -0.3% | 295,600 |
| 2024/02/05 | 1,966 | 1,966 | 1,929 | 1,951 | -24 | -1.2% | 216,500 |
| 2024/02/02 | 1,942 | 1,987 | 1,933 | 1,975 | +32 | +1.6% | 279,900 |
| 2024/02/01 | 1,835 | 1,963 | 1,824 | 1,943 | +100 | +5.4% | 515,200 |
| 2024/01/31 | 1,850 | 1,914 | 1,828 | 1,843 | +104 | +6% | 450,900 |
| 2024/01/30 | 1,781 | 1,792 | 1,729 | 1,739 | -39 | -2.2% | 124,300 |
| 2024/01/29 | 1,768 | 1,784 | 1,765 | 1,778 | +10 | +0.6% | 113,000 |
| 2024/01/26 | 1,760 | 1,788 | 1,757 | 1,768 | +13 | +0.7% | 146,300 |
| 2024/01/25 | 1,741 | 1,757 | 1,736 | 1,755 | +18 | +1% | 117,300 |
| 2024/01/24 | 1,740 | 1,747 | 1,731 | 1,737 | -23 | -1.3% | 89,900 |
| 2024/01/23 | 1,770 | 1,787 | 1,756 | 1,760 | -13 | -0.7% | 98,400 |
| 2024/01/22 | 1,758 | 1,779 | 1,758 | 1,773 | +15 | +0.9% | 78,000 |
| 2024/01/19 | 1,760 | 1,769 | 1,736 | 1,758 | +6 | +0.3% | 139,800 |
| 2024/01/18 | 1,734 | 1,759 | 1,729 | 1,752 | +15 | +0.9% | 93,200 |
| 2024/01/17 | 1,820 | 1,838 | 1,735 | 1,737 | -80 | -4.4% | 289,100 |
| 2024/01/16 | 1,835 | 1,849 | 1,813 | 1,817 | -3 | -0.2% | 280,300 |
| 2024/01/15 | 1,802 | 1,823 | 1,790 | 1,820 | +32 | +1.8% | 183,300 |
| 2024/01/12 | 1,738 | 1,798 | 1,715 | 1,788 | +59 | +3.4% | 270,800 |
| 2024/01/11 | 1,735 | 1,742 | 1,706 | 1,729 | +4 | +0.2% | 103,500 |
351～
400
件表示中 / 7025件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 249,200円 | +4.1% | -3.1% | 2.33% | 21.65倍 | 1.89倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 持田薬 | 313,500円 | +5.1% | -7.0% | 2.55% | 20.58倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 204,000円 | +3.1% | -6.5% | 2.35% | 9.47倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 151,900円 | -2.4% | -52.3% | 3.75% | 18.18倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ネクセラファーマ | 90,900円 | +20.3% | - | 0.00% | 161.17倍 | 1.24倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
